Posts associated with cfdna
Stabilization

FDA clearance brings liquid biopsy into a new era

With the FDA clearance of several assays, liquid biopsy moves closer toward the goal of making this screening method a standard of care. Liquid biopsy…
Read More
Stabilization

How can nucleic acids predict disease?

Liquid biopsy is a diagnostic technique where bodily fluids are examined for biomarkers that suggest disease. In recent years, liquid biopsy has been …
Read More
Why stabilization matters
Stabilization

Why does stabilization matter?

Human blood is packed with genetic information found in circulating cell-free DNA (cfDNA) and cell-free RNA (RNA). Liquid biopsy takes advantage of th…
Read More
Sequencing DNA
Stabilization

FDA drafts guidance on ctDNA

Earlier this year, the U.S. Food and Drug Administration released a draft guidance regarding the use of circulating tumor DNA (ctDNA) for early-stage …
Read More
Stabilization

Cleared assays advance liquid biopsy

The goal of liquid biopsy moved closer to reality in past weeks. Liquid biopsy is the use of a bodily fluid to collect information from a distant site…
Read More
Stabilization

GRAIL publication uses Streck tube

Streck’s Cell-Free DNA BCT® was used in a groundbreaking research study detailing the early detection of cancer utilizing a blood draw. Researc…
Read More
Stabilization

Key development for liquid biopsy research

A recent publication from the BloodPAC group seeks to standardize pre-analytical variables for liquid biopsies. Titled “Minimum Technical Data Eleme…
Read More
Stabilization

Clear advantage of glass BCTs

When choosing between glass or plastic blood collection tubes designed to maintain the cell-free DNA population, there is an often overlooked aspect w…
Read More
News/Events

Cell-Free DNA BCT featured in Nature

Researchers developing advanced methods for characterizing tumors through the analysis of circulating DNA in the bloodstream used Streck Cell-Free DNA…
Read More